3Commission of the European Communities. Proposal for a Regulation of the European Parliament and of the Council, Concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH). European Regulation of REACH (VOLUME I) ,2003,1:25.
4Van Der Jagt K, Munn S, Tφrslφv J, et al. Alternative Approaches can Reduce the Use of Test Animals under REACH. IHCP Report, 2004 : 1-31.
5Pedersen F, De Bruijn J, Munn S, et al. Assessment of additional testing needs under REACH. Effects of ( Q ) SARS, risk based testing and voluntary industry initiatives. European Commission Report, 2003 : 1-36.
6Commission of the European Communities. Proposal for a Regulation of the European Parliament and of the Council, Concerning the Registration, Evaluation, Authofisation and Restriction of Chemicals (REACH). European Regulation of REACH (VOLUME Ⅱ-Annexes Ⅰ to IX to the Proposal for a Regulation ), 2003,2 : 48- 80.
7Tennant RW.The National Center for Toxicogenomics:Using new technologies to inform mechanistic toxicology[J].Environ Health Perspect,2002,110(1):A8-10.
8Bellinger DC.Perspectives on incorporating human neurobehavioral end points in risk assessments[J].Risk Anal,2002,22(3):487-498.
9Liu B,Gao HM,Hong JS.Parkinson's disease and exposure to infectious agents and pesticides and the occurrence of brain injuries:role of neuroinflammation[J].Environ Health Perspect,2003,111(8):1065-1073.
10Letz R.Continuing challenges for computer-based neuropsychological tests[J].Neurotoxicology,2003,24(4-5):479-489.
